Gossamer Bio (GOSS) Change in Acquisitions & Divestments (2019 - 2026)

Gossamer Bio's Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $66.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 45.9% year-over-year to $66.6 million; the TTM figure through Mar 2026 stood at $319.9 million (down 35.9% YoY), while the FY2025 annual figure was $376.4 million, down 28.14% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $66.6 million, down from $87.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $147.8 million in Q1 2024, with the low at $40.0 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $86.0 million (2022), against an average of $90.3 million.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments jumped 1278.95% in 2022, then tumbled 55.45% in 2025.
• Gossamer Bio's Change in Acquisitions & Divestments stood at $86.0 million in 2022, then advanced by 23.14% to $105.9 million in 2023, then rose by 29.27% to $136.9 million in 2024, then plunged by 36.45% to $87.0 million in 2025, then dropped by 23.45% to $66.6 million in 2026.
• Business Quant data shows GOSS's Change in Acquisitions & Divestments at $66.6 million in Q1 2026, $87.0 million in Q4 2025, and $46.6 million in Q3 2025.